Published in Dig Dis Sci on October 01, 1997
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol (2000) 1.73
Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review. Dig Dis Sci (2012) 1.42
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
Helicobacter pylori and Hepatitis C Virus Coinfection in Egyptian Patients. J Glob Infect Dis (2010) 1.03
Extradigestive manifestations of Helicobacter pylori gastric infection. Gut (1999) 1.03
Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol (2016) 1.02
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol (2008) 1.00
Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci (2002) 1.00
Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut (2000) 0.98
Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis. Int J Clin Exp Med (2010) 0.95
Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci (2006) 0.93
State of the Globe: Helicobacter pylori and Hepatitis C Together Hamper Health. J Glob Infect Dis (2010) 0.91
Helicobacter pylori seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci (2002) 0.82
Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med (2008) 0.81
Gastric tissue oxidative changes in portal hypertension and cirrhosis. Dig Dis Sci (2007) 0.80
Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Dig Dis Sci (2003) 0.79
Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol (2015) 0.78
Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States. Hum Pathol (2007) 0.77
Gastric epithelial cell proliferation in patients with liver cirrhosis. Dig Dis Sci (2001) 0.77
Liver disease and Helicobacter. World J Gastroenterol (1999) 0.77
Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens. World J Gastrointest Pharmacol Ther (2015) 0.75
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol (1989) 3.73
Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol (1991) 3.19
Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers. Arch Intern Med (1988) 3.03
Helicobacter pylori. Am J Gastroenterol (1994) 2.88
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol (1989) 2.15
When is Helicobacter pylori infection acquired? Gut (1993) 1.94
The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol (1975) 1.67
Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci (1991) 1.40
The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol (1975) 1.38
Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis (1990) 1.35
Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg (1973) 1.29
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
The use and misuse of the chi-square test. Psychol Bull (1949) 1.21
The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors. J Med Microbiol (1990) 1.14
The prevalence of Campylobacter pylori gastritis among asymptomatic adults. CMAJ (1989) 1.14
High prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic Hispanics. J Clin Microbiol (1991) 0.92
Peptic ulceration in patients with chronic liver disease. Dig Dis Sci (1980) 0.91
Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol (1995) 0.91
PEPTIC ULCER AND GASTRIC SECRETION IN PATIENTS WITH LIVER DISEASE. Gut (1964) 0.89
Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci (1994) 0.89
Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci (1990) 0.88
Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut (1991) 0.87
Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc (1995) 0.85
Campylobacter pylori in central Africa. Br Med J (Clin Res Ed) (1988) 0.83
Serum IgG and IgA antibody responses to Campylobacter pylori in a group of healthy asymptomatic volunteers. Scand J Infect Dis (1989) 0.83
Terminology, definitions and diagnostic criteria in digestive endoscopy. With the collaboration of the members of the Terminology Committee of the World Society of Digestive Endoscopy/OMED. Scand J Gastroenterol Suppl (1984) 0.82
Portacaval anastomosis and peptic ulcer: a nonassociation. Gastroenterology (1975) 0.81
Frequency of upper gastrointestinal lesions in patients with liver cirrhosis. Dig Dis Sci (1988) 0.80
On the partitioning of contingency tables. Psychol Bull (1965) 0.75
Combined upper and lower gastrointestinal endoscopy: a prospective study in alcoholic and nonalcoholic cirrhosis. Alcohol Clin Exp Res (1989) 0.75
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med (1991) 4.60
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med (2012) 4.21
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene (2008) 4.11
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med (1996) 3.47
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Persistent hepatitis C viraemia without liver disease. Lancet (1993) 3.14
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med (2013) 2.93
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med (2013) 2.73
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology (1995) 2.63
Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med (2000) 2.40
Urease tests for Campylobacter pylori: care in interpretation. J Clin Pathol (1988) 2.35
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology (1985) 2.32
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology (1999) 2.30
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet (1989) 2.14
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev (2010) 2.09
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant (2008) 2.06
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
The role of gastroenterologists and digestive surgeons in ultrasonography. Ital J Gastroenterol (1992) 2.04
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer (1992) 2.01
Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis (2001) 1.99
Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology (1989) 1.99
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol (1997) 1.98
Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C. Hepatology (2000) 1.94
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology (1991) 1.82
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther (2005) 1.75
Duodenal ulcer, Helicobacter pylori, and gastric secretion. Gut (1994) 1.75
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology (1989) 1.70
Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett Appl Microbiol (2000) 1.70
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol (1994) 1.69
Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68
Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis (2008) 1.65
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther (2003) 1.57
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Adriamycin (NSC-123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep (1969) 1.56
Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension. Ultrasound Med Biol (2001) 1.56
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost (2012) 1.56
Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation. Am J Gastroenterol (1998) 1.54
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Four hour rapid urease test (RUT) for detecting Campylobacter pylori: is it reliable enough to start treatment? J Clin Pathol (1988) 1.53
The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis (2005) 1.52
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut (1989) 1.49
Lipid peroxidation and antioxidant status in adults receiving lipid-based home parenteral nutrition. Am J Clin Nutr (1998) 1.47
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut (2004) 1.44
Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol (1999) 1.43
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders. Ital J Gastroenterol Hepatol (1999) 1.43
Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Dig Liver Dis (2002) 1.42
No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol (1995) 1.42
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Family treatment of symptomatic children with Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1997) 1.41
Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci (1991) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. Hum Pathol (2004) 1.39
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia (2006) 1.36
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil (2007) 1.35
Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther (2003) 1.33
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci (1999) 1.29
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med (2012) 1.29
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. HIV Med (2011) 1.23
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol (2008) 1.22
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology (2000) 1.21